Product
Naldemedine
Aliases
Rizmoic
Name
SYMPROIC
INN Name
naldemedine
FDA Approved
Yes
3 clinical trials
1 organization
5 indications
1 document
Indication
Opioid-Induced ConstipationIndication
PancreatitisIndication
AcuteIndication
Opioid-Induced Bowel DysfunctionIndication
ConstipationClinical trial
A Phase 1/2, Multicentre, Open-label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Naldemedine in Paediatric Patients Who Are Receiving or Who Are About to Receive Treatment With OpioidsStatus: Recruiting, Estimated PCD: 2024-08-13
Clinical trial
Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute Pancreatitis An Investigator-initiated, Randomized, Placebo-controlled, Double-blind Clinical TrialStatus: Active (not recruiting), Estimated PCD: 2024-03-30
Clinical trial
The Effect of Naldemedine on Opioid-induced Bowel Dysfunction. An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled, Cross-over Clinical TrialStatus: Recruiting, Estimated PCD: 2025-03-01
Document
DailyMed Label: SYMPROICOrganization
BioDelivery Sciences International Inc